ABSTRACT The antigenic determinants of vertebrate metallothionein have been determined by a competitive-binding double-antibody radioimmunoassay to consist of two immunologically dominant regions in the NH2-terminal domain (residues 1-29). The COOH-terminal domain (residues 30-61) exhibited trivial immunoreactivity in competitive binding assays. The tryptic peptide encompassing residues Metallothionein is a 6,800-dalton metal-binding protein of unknown function isolated originally by Margoshes and Vallee (1). The protein is found in many cell types and is inducible by various metal ions (2-7) and glucocorticoids (8, 9) . Two sequence variants exist in the vertebrates thus far studied, and both are inducible. The protein is unusual in that it contains 32 mol % cysteine (20 of 61 residues in vertebrates), and all cysteine residues are involved in metal chelation (3, 4, (10) (11) (12) (13) (14) (15) (16) (17) (18) . Metallothionein has a stable tertiary conformation with the apoprotein being a random coil with possibly some short-range order (19, 20) . The structure appears to consist of two domains, each containing a metal-cysteine cage (21-23). Recently, Winge and Mildossy (24) showed that the two domains of Cd,Zn-thionein with seven metal atoms are separable by limited proteolysis. The COOH-terminal half of the molecule (residues 30-61) contained the four-metal atom-cysteine center (cluster A) and therefore the three-metal atom-cysteine center (cluster B) must be enfolded by the NH2-terminal half of the molecule (residues 1-29).
Metallothionein is a 6,800-dalton metal-binding protein of unknown function isolated originally by Margoshes and Vallee (1) . The protein is found in many cell types and is inducible by various metal ions (2) (3) (4) (5) (6) (7) and glucocorticoids (8, 9) . Two sequence variants exist in the vertebrates thus far studied, and both are inducible. The protein is unusual in that it contains 32 mol % cysteine (20 of 61 residues in vertebrates), and all cysteine residues are involved in metal chelation (3, 4, (10) (11) (12) (13) (14) (15) (16) (17) (18) . Metallothionein has a stable tertiary conformation with the apoprotein being a random coil with possibly some short-range order (19, 20) . The structure appears to consist of two domains, each containing a metal-cysteine cage (21) (22) (23) . Recently, Winge and Mildossy (24) showed that the two domains of Cd,Zn-thionein with seven metal atoms are separable by limited proteolysis. The COOH-terminal half of the molecule (residues 30-61) contained the four-metal atom-cysteine center (cluster A) and therefore the three-metal atom-cysteine center (cluster B) must be enfolded by the NH2-terminal half of the molecule (residues .
With the isolated domains and peptide fragments of rat metallothionein available, we were interested in determining the immunoreactive properties of the domains and fragments in comparison with those of the native protein. Vander Mallie and Garvey (25, 26) recently developed a sensitive double-antibody competitive-binding radioimmunoassay for metallothionein and the apoprotein using rabbit antiserum produced in response to injected rat metallothionein. With the assay, complete crossreactivity has been observed for metallothionein isolated from the livers of rat, horse, and human and also from Chinese hamster cells, as well as for Cu-thionein (7) and for Zn-thionein and apothionein (26) . Using this assay, we have determined the location of the antigenic sites of the molecule.
MATERIALS AND METHODS
Preparation of Protein and Peptides. Metallothionein was purified as described (3, 7) from the livers of rats injected subcutaneously with CdCl2. The a-fragment of metallothionein was prepared as described (24) . The a-fragments were prepared from both isoforms of metallothionein, designated Cd,Zn-MT-1 and Cd,Zn-MT-2. Purity of the a-peptides was assessed by amino acid analysis and NH2-terminal sequence analysis (24) .
The tryptic peptide OT1 (residues 1-25) was prepared by proteolysis of performic acid-oxidized thionein 2 with trypsin at a protease/thionein ratio (wt/wt) of 1:50 in 0.1 M pyridine acetate (pH 5) at 37°C for 48 hr. The tryptic peptides were resolved by gel filtration on a Sephadex G-50 column (1.5 X 160 cm) equilibrated with 1 M acetic acid as described by Huang et al. (15) . The effluent fractions (1.5 m per tube) were monitored by the fluorescamine reaction after alkaline hydrolysis. The fluorescence emission at 475 nm was monitored in a Perkin-Elmer 650-10S spectrophotometer with excitation at 390 nm. The peptide eluting first was shown to be tryptic peptide OT1, in that its amino acid composition was the same as that for OTl reported by Huang et Hirs (28) . The yield of S-carboxymethylcysteine was about 60%. The NH2-terminal acetylated methionine was removed by CNBr digestion in 70% formic acid using equal weights of solid CNBr and metallothionein. After 64 hr in the dark, the sample was dried by repeated lyophilization and then oxidized with performic acid as described above. Amino acid analysis of the CNBr-digested metallothionein failed to reveal the presence of methionine or methionine sulfone, whereas the aspartate content was normal, suggesting that the acid-labile bond between aspartate-2 and proline-3 was not hydrolyzed under the conditions used. Lysine residues in the oxidized thionein were modified by citraconylation as described (29) . Three 50-,l aliquots of citraconic anhydride were added to 2 ml of oxidized thionein at pH 8 over a 30-min period. The extent of blocking of the amino groups was monitored by the fluorescamine reaction (30) . Comparison of the fluorescence per nmol of citraconylated thionein with the fluorescence per nmol of fluorescamine-treated insulin A, which has Abbreviations: MT-1 and MT-2, isoforms 1 and 2 of metallothionein.
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Radioimmunoassay. The conditions for the double-antibody radioimmunoassay for determination of metallothionein have been described (31) . The antisera were from a rabbit (25) hyperimmunized with glutaraldehyde-polymerized MT-1. The native and modified metallothionein and peptide fragments described above were allowed to react as competitors with 1"Ilabeled metallothionein for the primary antibody (rabbit antirat liver metallothionein). Immunocomplexes were precipitated with a goat anti-rabbit immunoglobulin second antibody. In parallel with the sample assays, the assay was standardized by using known amounts of "2I-labeled rat liver metallothionein, to determine maximum bound and nonspecific bound values. Data handling is described in Fig. 1 and Table 2 . The data are presented in two forms for clarity and quantitative comparison. Precipitation Assay. To obtain a measure of the probable number of antigenic determinants of metallothionein, a precipitation assay was carried out essentially as described by Garvey et al. (32) , using equal volumes of a constant amount of rat metallothionein (obtained from a specific metallothionein antiserum by ammonium sulfate precipitation) and various amounts of metallothionein. The metallothionein was assayed for protein and for '09Cd content, the latter being used to fill the metal binding sites. Tubes were refrigerated for 8 to 9 days to allow complex formation to reach completion; during the incubation period, the tubes were removed at least once daily and mixed on a Vortex. A noncompact type of precipitate developed, which was heaviest in the middle of the metallothionein concentration range. The precipitates were collected by centrifugation and washed with borate-buffered saline that had been used as a diluent for the metallothionein and anti-metallothionein solutions. The anti-metallothionein component of the complexes was determined by the A2w value of the dissolved precipitates (using an absorption coefficient El*m of 14.3 for rabbit IgG and assuming a negligible contribution by metallothionein to the spectral properties of the dissolved complex at 280 nm); metallothionein was quantitated from the radioactivity present as 1'9Cd in the precipitates. Corrections were made for the blank consisting of anti-metallothionein in buffer.
RESULTS
Various samples of metallothionein were tested for their ability to compete with "2I-labeled thionein in a radioimmunoassay.
Competition assays were conducted at sample concentrations of 0.1-1,000 pmol, and the fraction of bound "2I-labeled metallothionein was determined. Data were analyzed by linear Q 1 10 Metallothionein, pmol 100 1,000
FIG. 1. Logit-log regression for rat metallothioneins and various derivatives in competitive binding radioimmunoassays (see Table 2 ). regression, using a logit transformation to express the dependence of the percentage of "2I-labeled bound protein on the quantity of the competing samples.
MT-1 and MT-2 of rat liver metallothionein (antigens 1 and 2) exhibited identical crossreactivities with the rabbit antisera prepared against rat liver MT-1 ( Fig. 1 and Table 2 ). Competition was apparent not only with the native isoforms of Cd,Znthionein but also with isoforms that had been denatured by performic acid oxidation (antigens 3 and 4). Removal of the metal ions in the protein has been shown to yield a random coil polypeptide conformation (33) . Oxidation of the cysteine residues to cysteic acid residues destroys the metal-binding sites and also introduces a charge repulsion that limits folding. comitant loss of the antigenic reactivity of the site. Elucidation of the immunoreactive determinants on various proteins has shown that they are usually on exposed surface regions and consist of a small number (usually 6 or 7) of residues (34, 35) . The hinge connecting the two domains in native metallothionein is not accessible for proteolysis (24) , suggesting that this hinge region is unlikely to be accessible to the antibody and therefore is unlikely to be immunoreactive.
Antigenic determinants can be predicted by analyzing amino acid sequences to find the point of greatest local hydrophilicity (36, 37) . This is accomplished by assigning each amino acid a numerical value based on solvent parameters and then repetitively averaging these values along hexapeptides in the polypeptide (38, 39) . The region of highest average hydrophilicity is invariably located in or adjacent to an antigenic determinant (36) . A plot of the hydrophilicity profile of the residues in human MT-2 calculated according to Hopp and Woods (36) is shown in Fig. 2 . Values for rat, rabbit, and human metallothionein isoforms are similar and show a maximum in the region of residues 20-25. An antigenic determinant would be predicted near residues 22 and 23 from the hydrophilicity data. This agrees with the results of the modification studies, which suggest immunoreactivity in the region of residues 20-25. Three other candidate regions exist, one near the NH2 terminus, a second at residues 27-32, and a third at residues 52-58. Modification studies also identified the NH2-terminal methionine as being significant in the interaction of thionein with the polyclonal antisera. The candidate region composed of residues [27] [28] [29] [30] [31] [32] probably does not participate significantly in immunoreactivity because it is an inaccessible hinge linking the two domains. The failure of the region involving residues 52-58 to elicit a significant immune response is perhaps due to the fact that it is less hydrophilic than calculated because of the influence of the adjoining hydrophobic regions. These results suggest that the polypeptide segments encompassing residues 1-5 and 20-25 are exposed to solvent and are thus prominent surface features on the metallothionein molecule. Neither the hydrophilic hinge region nor the segment comprised of residues [50] [51] [52] [53] [54] [55] [56] appear to be as exposed or prominent. These calculations did not take into account the contribution from the metal ions, which may affect the hydrophilicity of the folded polypeptide chain.
The antisera/protein combining ratio of 1.5 suggests one dominant immunogenic site and one weakly antigenic site. The interaction of the two sites would eventually produce a precipitating lattice with an antigen/antibody ratio (mol/mol) of 1:1. Precipitates would also form gradually when the weakly antigenic site was unoccupied by its specific antibody either because of dimer formation (41) or because of occlusion (42) , and these precipitates would have an antigen/antibody ratio of 2:1. Both processes would have to occur with approximately equal probabilities to produce the 1.5:1 ratio found in the precipitation assay. To test whether an interaction exists in the apoprotein between the two regions identified as antigenic sites, we note that complementation by modified peptides 12 and 14 (antigen 15) did not occur since the mixture did not elicit any immunoreactivity. This result, together with that of the precipitation experiment with 1ooCd labeling, supports the concept of two discrete regions of antigenicity.
Understanding that all antigenic determinants are conformational to various degrees (34, 43) and perhaps best considered as topographical (44) (45) (46) (47) , the actions of those of metallothionein are describable as sequential (48) in nature. There is but slight change in the response in the competitive binding assays in the cases of native metallothionein and denatured metallothionein, and Vander Mallie and Garvey (26) observed identity in crossreactivity for native metallothionein and the apoprotein. In addition, proton NMR data suggest that the apoprotein exists in a random coil configuration (33) .
The unfolding of a polypeptide usually abolishes the capacity of the protein to interact with an antibody to the native protein if the antigenicity of the determinants depends significantly on conformation. This has been shown with polyclonal antibodies for myoglobin (34) and for lysozyme (35) . The reactions of the antigenic determinants of ferredoxin (49) and tobacco mosaic virus protein (50) have been shown to be sequential in that small peptides can be isolated that are immunoreactive and could account for total protein immunoreactivity. Localization of antigenic determinants on peptide fragments is frequently difficult because the unfolding that occurs in the generation of the peptides can significantly decrease the affinity of the antibody for the determinant. This situation is not a problem in concluding that the metallothionein a-fragment has little immunoreactivity because the Cd4-a-fragment retains its native conformation, as shown by 113Cd NMR studies (51) . Neither the Cd2-afragment nor denatured a-fragment were immunoreactive, unlike denatured peptide OT1. Therefore, the immunological reactivity of metallothionein clearly resides in the NH2-terminal domain.
Vander Mallie and Garvey (26) have found that purified metallothioneins from equine liver, human liver, and rat liver MT-1 and MT-2 show complete crossreactivity, which implies that the antigenic determinants are preserved in the primary structure of these molecules. Since the determinants probably have a sequential action in nature, significant sequence homology presumably exists in the determinant regions [such a sequence homology is, for example, apparent in the determinants of cytochrome c (43) ]. A comparison of the known sequences of the thionein isoforms isolated from human (2), equine (2) , and rat (52, 53) liver is given below (amino acids are identified by the single-letter code). The peptide regions implicated in this study to be involved in antibody reactivity show marked homology.
Biochemistry: Winge and Garvey The results also indicate that in part the production in the rabbit of antisera to rat metallothionein is an autoimmune reaction. The sequences of the two determinants in rabbit and rat are identical for the NH2-terminal segment and differ by only one substitution (glutamine for glutamate) in the immunogenic region (54) . It has been shown that animals injected with autologous proteins are capable of eliciting an autoimmune response; therefore, the antigenicity of a protein is not dependent on the immunized host but is inherent in the structure of the molecule (55) .
Rabbit anti-rat metallothionein serum may be a useful tool in answering questions related to structure and function of metallothionein. It would be important in studying these questions to have antibodies specific for the two separate domains.
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